AVE 0.00% 0.2¢ avecho biotechnology limited

elixia/ body shaper to launch into usa, page-3

  1. 1,002 Posts.
    All good stuff at the AGM, but not a lot of new stuff.

    And today at the AGM - they said there will be another cap raising to fund the oxy trials - so while may be generally self funding by some time 2012 - decent cap raising is still to come. No timing or approximate timing could be given but I think if you look at the trial schedule you can probably make a fair stab at it.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.